St. Jude Medical Enrolls First Patient In FAME II Clinical Trial To Study Use Of FFR Technology In Patients With Stable Coronary Artery Disease

Links shared publicly online about this topic.

  • 1,138
    total visits

St. Jude Medical Enrolls First Patient In FAME II Clinical Trial To Study Use Of FFR Technology In Patients With Stable Coronary Artery Disease

medicalnewstoday.com —

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous

View full resource at medicalnewstoday.com

Tags: Circulation, Heart Disease, Circulatory Disorders, Atherosclerosis, Coronary Artery Disease, Thrombotic Event, Disease and Condition, Clinical Trial

  • Share

Most Recently Shared on May 28, 2010 at 4:06 am By:

mnt_cardiovasc MNT Cardiovascular

St. Jude Medical Enrolls First Patient In FAME II Clinical Trial To Study Use Of FFR Technology In Patients With Stabl... http://mnt.to/3D8z

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Heart News MNT Heart News

MNT Clinical Trials MNT Clinical Trials

Advertisement